Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2023
‘When’s our turn?’ PHARMAC's new funding won't cover breast cancer fighter's $100k bill
13 March 2023 - Hayley Steele has a hefty price tag on her life, one worth almost $100,000. ...
Posted by Michael Wonder on 12 Mar 2023
Medicare Part D coverage of anti-obesity medications — challenges and uncertainty ahead
11 March 2023 - Obesity is highly prevalent in the United States — affecting more than 41% of adults, including a ...
Posted by Michael Wonder on 08 Mar 2023
Biden calls for tax on the wealthy to extend Medicare funding
8 March 2023 - President Joe Biden this week called for higher taxes on wealthy Americans to extend Medicare funding as ...
Posted by Michael Wonder on 25 Feb 2023
Review of National Hospital Funding Agreement
24 February 2023 - The five-year agreement on public hospital funding between the Australian Government and all states and territories is ...
Posted by Michael Wonder on 21 Feb 2023
PHARMAC signals first step towards funding continuous glucose monitors
21 February 2023 - PHARMAC will soon be seeking competitive commercial offers for the supply of funded continuous glucose monitors ...
Posted by Michael Wonder on 10 Feb 2023
PHARMAC to get one time $66 million boost
10 February 2023 - The national drug-buying agency will get an extra $66 million in 2023 in a one-off cash ...
Posted by Michael Wonder on 31 Jan 2023
Options for a reformed Prostheses List pre-listing assessment framework and governance structure
31 January 2023 - This report provides a framework and proposes options for governance that would align the Prostheses List processes ...
Posted by Michael Wonder on 30 Jan 2023
Life sciences industry calls for better funding for medicine and technology regulator
31 January 2023 - The life sciences, health and medicine sectors have come together to call for improved funding of ...
Posted by Michael Wonder on 29 Jan 2023
Government must place a higher value on vaccines and medicines that deliver long term benefits
30 January 2023 - Medicines Australia has used its budget submission to remind Government of its commitment to lower Australia’s ...
Posted by Michael Wonder on 19 Dec 2022
US health insurance coverage and financing
17 December 2022 - The Covid-19 pandemic has shone a spotlight on the fragmented nature of the US health care system. ...
Posted by Michael Wonder on 19 Dec 2022
PHARMAC funds more treatments for people with inflammatory bowel disease
20 December 2022 - Pharmac has today announced funding of ustekinumab (Stelara) for people with inflammatory bowel disease (IBD) and ...
Posted by Michael Wonder on 06 Dec 2022
PHARMAC and a very curious case of media management
6 December 2022 - PHARMAC’s funding of Trikafta is a huge win for people with cystic fibrosis. But the media management ...
Posted by Michael Wonder on 30 Nov 2022
The Government may have taken money from the DHB hospital budget to increase PHARMAC's funding
30 November 2022 - In this year’s budget, the Government said it has increased PHARMAC's funding by 43% over the ...
Posted by Michael Wonder on 01 Nov 2022
PHARMAC seeks feedback on the funding of paediatric cancer medicines
2 November 2022 - PHARMAC is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that ...
Posted by Michael Wonder on 25 Oct 2022
Budget October 2022–23: strengthening Medicare
25 October 2022 - The Australian Government’s 2022-23 Budget begins the task of strengthening Medicare after a decade of cuts and ...